Also known as Ddavp, Stimate, and Minirin
Desmopressin (trade names: DDAVP, DesmoMelt, Stimate, Minirin) is a synthetic replacement for vasopressin, the hormone that reduces urine production. It may be taken nasally, intravenously, or as an oral or sublingual tablet. Physicians prescribe desmopressin most frequently for treatment of diabetes insipidus, bedwetting, or nocturia.Source: Wikipedia
DEA Class 2 meaning a high potential for abuse, less abuse potential than Schedule I drugs, with use potentially leading to severe psychological or physical dependence.
Estimated Total Cost: $128.27 for an average of 28 days supply
Patients are most commonly prescribed desmopressin to treat attention deficit hyperactivity disorder (adhd), bedwetting, von willebrand disease, and diabetes insipidus.